Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression

Journal: Nature Immunology

Published: 2019-06-03

DOI: 10.1038/s41590-019-0400-7

Affiliations: 20

Authors: 37

Go to article
Institutions Share
Department of Molecular and Cellular Oncology, MD Anderson Cancer Center, United States of America (USA) 0.31
Dan L Duncan Comprehensive Cancer Center, United States of America (USA) 0.11
Department of Biochemistry and Molecular Biology, UTHealth, United States of America (USA) 0.11
Department of Molecular and Cellular Biology, BCM, United States of America (USA) 0.07
Department of Biology and Biochemistry, UH, United States of America (USA) 0.05
University of Texas Graduate School of Biomedical Sciences (GSBS), United States of America (USA) 0.05
Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, United States of America (USA) 0.04
Yale Department of Immunobiology, United States of America (USA) 0.03
Department of Systems Biology, MD Anderson Cancer Center, United States of America (USA) 0.03
Duke Division of Surgical Sciences, United States of America (USA) 0.03
China Medical University (CMU), Taiwan 0.03
Department of Pathology, MD Anderson Cancer Center, United States of America (USA) 0.03
Department of Breast Medical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.03
Division of Surgery, MD Anderson Cancer Center, United States of America (USA) 0.02
Department of Breast Surgical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.02
Department of Immunology, MD Anderson Cancer Center, United States of America (USA) 0.01
Division of Basic Science Research, MD Anderson Cancer Center, United States of America (USA) 0.01
College of Life Sciences (CLS), ZJU, China 0.01
UPMC Genome Center (UGC), IPM, United States of America (USA) 0.01
Center for RNA Interference and Non-Coding RNAs (RNA Center), United States of America (USA) 0.01

Return